Clinical Trial Update: Anakinra in Myositis [Phase 2, Phase 3]

View source ↗

Summary

Karolinska Institutet-sponsored Phase 2 and Phase 3 trials evaluated anakinra for polymyositis and dermatomyositis (myositis), with inclusion body myositis list…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Inclusion Body Myositis
• Polymyositis

Drugs mentioned

• Anakinra (Kineret) (Anakinra)

Snippet

Sponsor: Karolinska Institutet | Conditions: Polymyositis, Dermatomyositis | Phase 2, Phase 3 | Status: COMPLETED